FPAS
RDY icon

Focus Partners Advisor Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Focus Partners Advisor Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
13,190
+687
+5% +$9.27K ﹤0.01% 1178
2026
Q1 		$173K Sell
12,503
-165
-1% -$2.3K ﹤0.01% 1173
2025
Q4 		$178K Sell
12,668
-367
-3% -$5.15K ﹤0.01% 1038
2025
Q3 		$176K Buy
+13,035
New +$188K ﹤0.01% 1080

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Focus Partners Advisor Solutions's RDY Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Dr. Reddy's Laboratories (RDY) stake by 5.5% in Q2 2026, buying an estimated $9.27K and bringing the position to 13,190 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Focus Partners Advisor Solutions first reported a position in RDY in Q3 2025 and has held it in 4 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Focus Partners Advisor Solutions held 13,190 shares of Dr. Reddy's Laboratories worth $193K as of Q2 2026.
  • Focus Partners Advisor Solutions bought 687 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $9.27K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1178 holding.
  • Focus Partners Advisor Solutions first reported a position in Dr. Reddy's Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.